NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) - ANVISA Registration 10158120418

Access comprehensive regulatory information for NUCLEAR IMMUNOGLOBULIN M FOR HEPATITIS B VIRUS (ANTI-HBC IGM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10158120418 and manufactured by manufacturer not specified. The registration is held by BIOMERIEUX BRASIL INDUSTRIA E COMERCIO DE PRODUTOS LABORATORIAIS LTDA with validity until Dec 18, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.